Get started

Genomics

$BNGO #stock forming a textbook bull flag. Strap in 🚀BNGO (Bionano Genomics) is forming a textbook bull flag. This comes on the heels of a share offering, which is important. Share offerings dilute the value of the stock in the short term, but if general sentiment remains bullish, provides a buying opportunity for a takeoff after the retracement. Well, now we also have a bullish continuation pattern in the form of a bull flag, which sets us up beautifully because we don't have to guess. We can wait for a breakout or a rejection here. If we get rejected I'll be laddering my buys from $4.50 to $3.50. More prudent traders can just wait for a breakout or a breakdown of the pattern without even buying. It's all about not navigating these waters blindly. Patterns are our north star in this brutal game. Immediate targets in the case of a breakout are $7, but due to all of the fundamentals around this company I believe double digits is inevitable.
NASDAQ:BNGO
by TheTravel1ngTrader
7
BNGO BioNano Genomics upside potenial, huge volume comingBioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. Net Income $-29,820,000.00 Market Cap $69.23 million Annual Sales $10.13 million BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:BNGOLong
by TopgOptions
ILLUMINA (ILMN) potential breakout over resistance $372ILMN is one of the highest conviction picks by ARKK investments (ARKK). They invest in disruptive technology that could potentially change the world. Another pick Invitae(NVTA) has a similar pattern and broke out recently. Level exhaustion at the $372 level and a potential accumulation zone. A daily close above 372 would be bullish. An overall bullish sentiment with the price well above the moving averages. Some key metrics I looked at, 3Y revenue growth: 13.89% ROIC: 14.22% P/CF: 48.54 P/S: 15.48 DCF value: $162 (Simply Wall street) PEG: 2.2X Future growth: 26.8% Historical growth: 17.6% Rule of 40 = net margin + revenue growth = 29+13= 42 (42>40, OK) Potential tailwinds, - Leader by market share (More than 90%) - Relatively new industry - Covid19 accelerating genome revolution and health trends - The decline in cost curve
NASDAQ:ILMNLong
by ashainp
2
Small Biotech Out Of Favor But Smart Buys Can Pay OffThe deep freeze has taken over small cap land. It has been a long time since small caps were out of vogue but the time has come. As the great rotation of capital shifts from high risk stocks to low risk, high dividend payers, many think the end has come for any investments in small caps. I am here to say that is not true. Over the past year, you could have closed your eyes and thrown a dart at a small cap and made a lot of money. Those times have changed, however there is still money to be made. You must now start analyzing the charts and buy at the key levels. For example, on no news, Rosetta Genomics Ltd. (NASDAQ:ROSG) has fallen from over $6.50 to $3.45. This monster drop is now crossing the 200 moving average and heading to gap fill at $3.20. This $3.20 level will be where the stock price has been cut in half as well as major support. At this discount, the stock becomes extremely attractive to tuck away a small position. Another biotech stock approaching a key level is OXiGENE Inc (NASDAQ:OXGN). Good news drove it to $5.40, however the risk adverse market has taken it down to $2.59. There is a key gap fill at $2.43 that offers a very intriguing risk to reward opportunity. Always remember small cap stocks are very high risk. Most likely the way to trade these plays is to be in, get a solid bounce and take profits. Gareth Soloway Chief Market Strategist www.InTheMoneyStocks.com
RLong
by InTheMoney_Stocks